Glaukos Corp. (GKOS) Misses Q2 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. BROS
5. FIS
6. DDOG
7. QCOM
8. EW
9. ZG
10. W

Go back to Glaukos Corp. (GKOS) Misses Q2 EPS by 14c

Glaukos Corporation Announces Second Quarter 2015 Financial Results

August 12, 2015 4:02 PM EDT

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the second quarter ended June 30, 2015. Key highlights of the quarter, compared to the same period in 2014, include:

Achieved 60% net sales growth to $17.8 million Expanded the gross margin to approximately 82% Completed an initial public offering (IPO), issuing 6.9 million shares and raising $113.7 million in net proceeds after deducting... More